Beijing Winsunny Pharmaceutical CO.LTD - Asset Resilience Ratio

Latest as of June 2025: 10.89%

Beijing Winsunny Pharmaceutical CO.LTD (601089) has an Asset Resilience Ratio of 10.89% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Beijing Winsunny Pharmaceutical CO.LTD (601089) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥511.00 Million

≈ $74.78 Million USD Cash + Short-term Investments

Total Assets

CN¥4.69 Billion

≈ $686.40 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how Beijing Winsunny Pharmaceutical CO.LTD's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 601089 total assets.

Liquid Assets Composition Over Time

This chart breaks down Beijing Winsunny Pharmaceutical CO.LTD's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Beijing Winsunny Pharmaceutical CO.LTD balance sheet liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥511.00 Million	10.89%
Total Liquid Assets	CN¥511.00 Million	10.89%

Asset Resilience Insights

Moderate Liquidity: Beijing Winsunny Pharmaceutical CO.LTD has 10.89% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Beijing Winsunny Pharmaceutical CO.LTD Industry Peers by Asset Resilience Ratio

Compare Beijing Winsunny Pharmaceutical CO.LTD's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Piramal Pharma Limited NSE:PPLPHARMA	Drug Manufacturers - Specialty & Generic	0.73%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Zhejiang Medicine Co Ltd SHG:600216	Drug Manufacturers - Specialty & Generic	1.85%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)

The table below shows the annual Asset Resilience Ratio data for Beijing Winsunny Pharmaceutical CO.LTD.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	32.78%	CN¥1.58 Billion ≈ $231.06 Million	CN¥4.82 Billion ≈ $704.82 Million	+28.14pp
2021-12-31	4.64%	CN¥100.00 Million ≈ $14.63 Million	CN¥2.15 Billion ≈ $315.08 Million	+1.73pp
2020-12-31	2.91%	CN¥50.00 Million ≈ $7.32 Million	CN¥1.72 Billion ≈ $251.21 Million	--

pp = percentage points

About Beijing Winsunny Pharmaceutical CO.LTD

SHG:601089 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.11 Billion

CN¥7.56 Billion CNY

Market Cap Rank

#8490 Global

#2010 in China

Share Price

CN¥15.76

Change (1 day)

+1.94%

52-Week Range

CN¥15.46 - CN¥30.27

All Time High

CN¥31.88